Page last updated: 2024-10-28

haloperidol and Cerebral Small Vessel Diseases

haloperidol has been researched along with Cerebral Small Vessel Diseases in 1 studies

Haloperidol: A phenyl-piperidinyl-butyrophenone that is used primarily to treat SCHIZOPHRENIA and other PSYCHOSES. It is also used in schizoaffective disorder, DELUSIONAL DISORDERS, ballism, and TOURETTE SYNDROME (a drug of choice) and occasionally as adjunctive therapy in INTELLECTUAL DISABILITY and the chorea of HUNTINGTON DISEASE. It is a potent antiemetic and is used in the treatment of intractable HICCUPS. (From AMA Drug Evaluations Annual, 1994, p279)
haloperidol : A compound composed of a central piperidine structure with hydroxy and p-chlorophenyl substituents at position 4 and an N-linked p-fluorobutyrophenone moiety.

Cerebral Small Vessel Diseases: Pathological processes or diseases where cerebral MICROVESSELS show abnormalities. They are often associated with aging, hypertension and risk factors for lacunar infarcts (see LACUNAR INFARCTION); LEUKOARAIOSIS; and CEREBRAL HEMORRHAGE.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Engin, EF1
Polat, B1
Ertan Akan, G1
Akgül, E1

Other Studies

1 other study available for haloperidol and Cerebral Small Vessel Diseases

ArticleYear
Cerebral proliferative angiopathy accompanied by cerebral cavernous malformation: A case report.
    Clinical neurology and neurosurgery, 2021, Volume: 210

    Topics: Adult; Anticonvulsants; Antipsychotic Agents; Cerebral Small Vessel Diseases; Gabapentin; Haloperido

2021